CVB homepage

Abbott’s HeartMate 3 left ventricular assist device (LVAD) has been implanted in thousands of U.S. patients in recent years.According to a new investigative report from CBS News and KFF Health News, however, safety data related to the device have raised questions in certain parts of the healthcare industry.

Researchers tracked years of data, noting that strokes and other neurological adverse events reduce a patient's odds of survival.  

Houston-based Leader Formulas is recalling one lot of its Rapture Preworkout dietary supplement due to the presence of 1,3-dimethylamylamine (DMMA), an ingredient not listed on the product label.

The product at the heart of this recall is a dietary supplement taken to boost energy and performance when exercising. The FDA previously warned the public not to take it due to the potential side effects. 

Video: Rick Snyder, MD, FACC, president of HeartPlace, and Chief Physician Executive at U.S. Heart and Vascular, testified to Congressional leaders in his role with the American Independent Medical Practice Association (AIMPA) to explain how federal healthcare policies have created an inefficient payment system that rewards higher cost care models and is putting lower cost private practices out of business.

"We really should have a system that is patient-centric, physician-led, and professionally managed, but in a cost-effective way," Rick Snyder, MD, said.

female cardiologist

Newsweek and Statista have shared their 2027 list of the world’s top 300 hospitals for cardiology. Nine of the top 20 are based in the United States.

cardiologist heart model doctor

The overall mortality rate for U.S. patients with cardiovascular disease has improved significantly in recent years. At the same time, however, care gaps remain that must be addressed.

The entrance to the AHA expo and technology floor. Photo by Dave Fornell #AHA22

The studies all answer key clinical questions, highlighting a variety of new technologies, drugs and techniques. 

Innovation at work

For hospitals, health systems and physician groups, effective cardiovascular strategic planning is the foundation for better cardiovascular care delivery, stronger service line performance and sustainable program growth. This article offers a practical approach for cardiovascular leaders who want a service line strategy that is more than a document.

Sponsored by MedAxiom